Select the Abstracts by Number

Click    to view the poster

232   Evaluation of OraQuick HIV-1/2 Rapid Test and a Rapid/ Simple Test Algorithm in a High- Risk/High-Prevalence Population in Bangkok, Thailand.

233   HAART Reduces the Sensitivity of OraQuick HIV1/2, a Developmental Rapid Test Directed Against a gp41 Peptide for HIV Diagnosis Using Oral Fluids or Serum.

234   Routinely Recommending HIV Testing at a Large Urgent Care Center (UCC): Assessing an "Opt-Out" Strategy with Standard Versus Rapid HIV Testing.

235   Failure of Serologic Assays for Diagnosis of Hepatitis B and C Virus Infections in Patients with Advanced HIV.

236   Rates of False-Positive Results on Quantitative HIV RNA Assays.

237   A Single Rapid Real- Time Monitored Isothermal RNA Amplification Assay for Quantification of HIV-1 Isolates from Groups M, N, and O.

238  Clinical Utility of a Quantitative Real-Time LightCycler PCR Assay forPneumocystis carinii.

239   NucliSens EasyQ HIV-1: A Novel Viral Load Assay Based on Real-Time NASBA.

240   Comparative Performance of Three Viral Load Assays on HIV-1 Viral Isolates Representing Group M Subtypes A G and Group O.

241   Are Measurements of Genital HIV-1 Viral Load in Women Reproducible?

242   Reliability and Correlations of Repeated Viral Load Measures in Plasma and Gut Mucosa (GALT) To Determine Baseline Characteristics in Clinical Trials.

243   Real-Time HIV-1 PCR for the Diagnosis of Infection in Newborns of African Mothers.

244   Advantage of Combined HIV Antibody and p24 Antigen Assays to 3rd-Generation HIV Assays in the Diagnosis of HIV Infection.

245   Combined HIV Antigen and Antibody Assay on a Fully Automated Chemiluminescence Analyzer To Shorten the Seroconversion Window.

246   HIV-1 Surveillance in Vietnam: Correlation between V3 Peptide-Based Serotyping and Sequence-Based Genotyping.

247   Feasibility of a Subtype- Specific Hybridization Assay forenvGenotyping of Subtypes A through G Including Discrimination of Recombinant Forms CRF01-AE and CRF02-AG.

248   Comparison of Capillary Electrophoresis Sequencing with the New CEQ 2000 System (Beckman Coulter Inc.) to Conventional Gel-Based Systems for HIV-1 Drug Resistance Analysis.

249   Validation of the Ultrasensitive HIV-1 Genotyping Assay.

250   Performance of the Applied Biosystems ViroSeq HIV- 1 Genotyping System for Analysis of Pediatric Plasma Samples.

251   Worldwide Evaluation of Genotypic Resistance Analysis Using Clinical HIV-I Isolates with Complex Drug Resistance Profiles.

252    A Quality Control Trial for HIV-1 Drug Resistance Testing Using Clinical Samples.

253   HIV Drug Resistance in the Texas Department of Criminal Justice.

254   Determination of a Clinically Relevant Phenotypic Resistance "Cutoff" for Abacavir Using the PhenoSense Assay.

255   A Rapid, Automated, Inexpensive Assay for Point Mutations in HIV-1 pol Associated with Resistance to Antiretrovirals.

256   Detection and Quantification of Minor HIV-1 Populations with Multiple Drug Resistance-Associated Mutations in Reverse Transcriptase by an Oligonucleotide Ligation Assay.